Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan
22. August 2024 09:00 ET
|
Inhibitor Therapeutics, Inc.
TAMPA, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. ("Inhibitor") (OTCQB: INTI) today provided an update on development efforts for its itraconazole formulation for the...
Momentum for higher welfare broiler chicken grows as nine leading food businesses join the U.S. Working Group for Broiler Welfare
25. August 2022 06:00 ET
|
Compassion in World Farming USA
New York City, NY, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Nine new leading food businesses join the U.S. Working Group for Broiler Welfare, bringing the group to 16 members. The doubling of members...
Biofrontera provides update on clinical developments
22. Juni 2021 09:00 ET
|
Biofrontera AG
Leverkusen, Germany, June 22, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today provides an...
The Canadian Bioceutical Corporation Announces Name Change to MPX Bioceutical Corporation
02. November 2017 18:54 ET
|
The Canadian Bioceutical Corporation
Election of Board of DirectorsAppoint Deloitte LLP as AuditorAppointment of OfficersIssuance of Stock OptionsEntering into Executive Services Agreement with Canadian Capital, LLC TORONTO, Nov. 02,...
BCC Provides Update on Health Canada Licensed Producer Application and Owen Sound Facility Build Out
26. Oktober 2017 07:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced it has completed preparatory construction work and...
BCC Announces Initial US$10 Million Drawdown on Credit Facility
24. Oktober 2017 18:20 ET
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 24, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that it made an initial drawdown of US$10 million under...
BCC Signs Definitive Agreement to Expand Into Second Adult Use Market
13. Oktober 2017 07:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that, the Company, through its wholly-owned U.S....
BCC Reports Q1 Fiscal 2018 Results
28. September 2017 21:35 ET
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 28, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) reported its financial results for the first quarter of fiscal 2018,...
BCC Reports Q4 and Fiscal 2017 Results
08. September 2017 07:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 08, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today reported its financial results for the fourth quarter and full...
BCC to Enter Into Joint Venture With Israeli Pharmaceutical Company Panaxia
22. August 2017 07:00 ET
|
The Canadian Bioceutical Corporation
Differentiation into high-growth market segment under new “Salus Bio-Pharma” brand JV will launch in Arizona & Massachusetts and, post closing of the acquisitions, in Nevada and Maryland. ...